White Marvin L — SEC Form 4 filings
SEC reporting owner CIK 1493324. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-30 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 14,287 shares, $171,015 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 14,287 shares @ $11.97 ($171,015) in Emergent BioSolutions Inc., filed 2024-11-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | Director | 4 | — | 1 leg · 14,287 sh · $171,015 | 6 |
| Aptevo Therapeutics Inc. (APVO) | Executive Chair, Director | 7 | — | — | 19 |
Form 4 filings — White Marvin L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Aptevo Therapeutics Inc. (APVO) | Option exercise (M): 1 · Option exercise (M): 1,666 · Tax withholding (F): 406 @ $4.07 · Option exercise (M): 1 (derivative) @ $0 · Option exercise (M): 1,666 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 25,344 @ $0 · Grant/award (A): 11,296 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Aptevo Therapeutics Inc. (APVO) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-07-21 | 4 | Aptevo Therapeutics Inc. (APVO) | Option exercise (M): 10 · Option exercise (M): 10 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 34,403 @ $0 · Grant/award (A): 15,824 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Aptevo Therapeutics Inc. (APVO) | Option exercise (M): 8 · Option exercise (M): 6 · Option exercise (M): 8 (derivative) @ $0 · Option exercise (M): 6 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | Emergent BioSolutions Inc. (EBS) | Sale (S): 14,287 @ $11.97 | EDGAR |
| 2024-07-19 | 4 | Aptevo Therapeutics Inc. (APVO) | Grant/award (A): 22,325 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 17,430 @ $0 · Grant/award (A): 25,748 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Aptevo Therapeutics Inc. (APVO) | Option exercise (M): 12,917 · Option exercise (M): 9,584 · Option exercise (M): 12,917 (derivative) @ $0 · Option exercise (M): 9,584 (derivative) @ $0 | EDGAR |
| 2024-01-30 | 4 | Aptevo Therapeutics Inc. (APVO) | Option exercise (M): 4,792 · Option exercise (M): 4,792 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1493324 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →